20th week of 2021 patent applcation highlights part 10 |
Patent application number | Title | Published |
20210145806 | Methods of Treating Brain Cancer and Related Diagnostic Methods | 2021-05-20 |
20210145807 | SINGLE-DOSE, READY-TO-USE INJECTABLE FORMULATIONS | 2021-05-20 |
20210145808 | Composition for Protecting Cardiomyocyte | 2021-05-20 |
20210145809 | COMPOUNDS FOR USE IN REGULATING FOLLICLE MATURATION | 2021-05-20 |
20210145810 | XANOMELINE DERIVATIVES AND METHODS FOR TREATING NEUROLOGICAL DISORDERS | 2021-05-20 |
20210145811 | TREATMENT OF CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE | 2021-05-20 |
20210145812 | AMINOAMIDE COMPOUNDS | 2021-05-20 |
20210145813 | COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE | 2021-05-20 |
20210145814 | TREATMENT OF PAIN WITH SEROTONIN-3 RECEPTOR AGONIST | 2021-05-20 |
20210145816 | PHARMACEUTICAL FORMULATION OF LONAFARNIB WITH A SULFOBUTYLETHER BETA-CYCLODEXTRIN | 2021-05-20 |
20210145817 | APIXABAN FORMULATIONS | 2021-05-20 |
20210145818 | COMPOSITIONS INFUSED WITH NICOTINE COMPOUNDS AND METHODS OF USE THEREOF | 2021-05-20 |
20210145819 | TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS | 2021-05-20 |
20210145820 | METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS | 2021-05-20 |
20210145821 | COMPOUNDS FOR THE TREATMENT OF CANCER | 2021-05-20 |
20210145822 | Novel Spirolactone Compounds | 2021-05-20 |
20210145823 | CRENOLANIB FOR TREATING FLT3 MUTATED PROLIFERATIVE DISORDERS ASSOCIATED MUTATIONS | 2021-05-20 |
20210145824 | MODULATORS OF CELLULAR ADHESION | 2021-05-20 |
20210145826 | TREATMENT OF SKIN DISORDERS BY TOPICAL ADMINISTRATION OF VEGF INHIBITORS | 2021-05-20 |
20210145827 | ANTIBIOTIC GEL FORMULATION AND METHODS OF PREPARING THE ANTIBIOTIC GEL FORMULATION | 2021-05-20 |
20210145828 | Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy | 2021-05-20 |
20210145829 | ORGANIC COMPOUNDS | 2021-05-20 |
20210145830 | MATERIALS AND METHODS FOR TREATING CANCER | 2021-05-20 |
20210145831 | CRYSTALLINE FORMS OF 5-BROMO-2,6-DI(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE AND NEW SALTS | 2021-05-20 |
20210145832 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | 2021-05-20 |
20210145833 | Methods and Compositions for Hair Growth by Activating Autophagy | 2021-05-20 |
20210145834 | COMBINATION OF POZIOTINIB WITH CYTOTOXIC AGENT AND/OR OTHER MOLECULARLY TARGETED AGENT AND USE THEREOF | 2021-05-20 |
20210145835 | METHODS FOR THE TREATMENT OF HER2 AMPLIFIED CANCER | 2021-05-20 |
20210145836 | PRODUCTION OF STERILE ACTIVE PHARMACEUTICAL INGREDIENTS | 2021-05-20 |
20210145837 | TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF USE THEREOF | 2021-05-20 |
20210145838 | SELECTIVE PDE4D INHIBITORS AGAINST DEMYELINATING DISEASES | 2021-05-20 |
20210145839 | INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY | 2021-05-20 |
20210145840 | T-CELL LYMPHOMA TREATMENTS | 2021-05-20 |
20210145841 | ENHANCEMENT OF DELIVERY OF LIPOPHILIC ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | 2021-05-20 |
20210145842 | NEW THERAPEUTIC USES | 2021-05-20 |
20210145843 | COMPOSITIONS AND METHODS ASSOCIATED WITH HAPTOGLOBIN RELATED PROTEIN | 2021-05-20 |
20210145844 | COMBINATION THERAPY FOR NICOTINE ADDICTION | 2021-05-20 |
20210145845 | METHODS FOR ACUTE AND LONG-TERM TREATMENT OF ALCOHOL DEPENDENCE USING IBOGAINE AND DERIVATIVES THEREOF | 2021-05-20 |
20210145846 | HIGH-CONCENTRATION FULVESTRANT COMPOSITIONS | 2021-05-20 |
20210145847 | TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS | 2021-05-20 |
20210145848 | OXYSTEROLS AND METHODS OF USE THEREOF | 2021-05-20 |
20210145849 | ORAL DISSOLVABLE FILM CONTAINING VITAMIN D3 | 2021-05-20 |
20210145850 | COMPOSITION, FOR OSTEOARTHRITIS TREATMENT, COMPRISING HYDROPHILIZED SULFASALAZINE AND HYALURONIC ACID AND METHOD FOR PREPARING SAME | 2021-05-20 |
20210145851 | TRYPTAMINE COMPOSITIONS FOR ENHANCING NEURITE OUTGROWTH | 2021-05-20 |
20210145852 | Combination Therapies for Treating Muscular Dystrophy | 2021-05-20 |
20210145853 | ANTI-INFLAMMATORY COMPOSITION INCLUDING NOVEL QUERCETIN-BASED COMPOUND | 2021-05-20 |
20210145854 | METHODS FOR INHIBITING MICROBE GROWTH | 2021-05-20 |
20210145855 | METHODS FOR ENHANCING CYTOTOXIC CANCER THERAPY THROUGH MODULATION OF PURINE BIOSYNTHESIS PATHWAYS | 2021-05-20 |
20210145856 | METHODS OF TREATING TUMOR METASTASIS | 2021-05-20 |
20210145857 | Compositions and Methods for Altering Tissue Specificity and Improving AAV9-Mediated Gene Transfer | 2021-05-20 |
20210145858 | Compositions for Renal Disease | 2021-05-20 |
20210145859 | MIR-17.about.92 AS THERAPEUTIC OR DIAGNOSTIC TARGET OF MOTOR NEURON (MN) DEGENERATION DISEASES | 2021-05-20 |
20210145860 | COMPOSITIONS, METHODS AND USES OF MESSENGER RNA | 2021-05-20 |
20210145861 | CHITOSAN CONTAINING COMPOSITIONS AND METHODS RELATING TO SAME | 2021-05-20 |
20210145862 | HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR ENHANCING EPITHELIAL SURVIVAL AND RECONSTITUTION OF BODY SURFACES | 2021-05-20 |
20210145863 | LUBRICATED SUBSTRATES COMPRISING LAMBDA-CARRAGEENAN | 2021-05-20 |
20210145864 | COMPOSITIONS COMPRISING PALMITOYLETHANOLAMIDE AND HYDROGEN WATER, AND METHODS THEREOF | 2021-05-20 |
20210145865 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASE INDUCED BY OXIDATIVE STRESS | 2021-05-20 |
20210145866 | Materials and Methods Relating to Stabilised Polymeric Silicate Compositions | 2021-05-20 |
20210145867 | PLASMONIC ENHANCED MAGNETIC NANOPARTICLES HYPERTHERMIA | 2021-05-20 |
20210145868 | COMPOSITIONS | 2021-05-20 |
20210145870 | Silver Palladium and Silver Platinum Nanoparticles Useful as Antimicrobial and Anticancer Agents | 2021-05-20 |
20210145871 | METHOD OF INCREASING THE HALF-LIFE OF HYDROGEN PEROXIDE WITH POLYPHENOLS | 2021-05-20 |
20210145872 | METHODS OF TISSUE GENERATION | 2021-05-20 |
20210145873 | Method of Controlling Administration of Cancer Antigen | 2021-05-20 |
20210145874 | SUPERNATANT FROM A COCULTURE OF MACROPHAGES AND IRRADIATED LEUKOCYTES, FOR CONTROLLING TUMOUR PROGRESSION OR RESTORING ANTI-TUMOR IMMUNITY | 2021-05-20 |
20210145875 | Blood Plasma Fractions for Use in Liver Regeneration | 2021-05-20 |
20210145876 | NOVEL ONCOLYTIC VIRUSES FOR SENSITIZING TUMOR CELLS TO KILLING BY NATURAL KILLER CELLS | 2021-05-20 |
20210145877 | METHODS OF USING TUMOR INFILTRATING LYMPHOCYTES IN DOUBLE-REFRACTORY MELANOMA | 2021-05-20 |
20210145878 | ANTI-CD79 CHIMERIC ANTIGEN RECEPTORS, CAR-T CELLS, AND USES THEREOF | 2021-05-20 |
20210145879 | Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment | 2021-05-20 |
20210145880 | BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20 | 2021-05-20 |
20210145881 | METHODS AND MATERIALS FOR TREATING GRAFT-VERSUS-HOST DISEASE | 2021-05-20 |
20210145882 | METHODS FOR ADOPTIVE CELL THERAPY TARGETING ROR1 | 2021-05-20 |
20210145883 | Modification of Immune Cells to Increase Activity | 2021-05-20 |
20210145884 | ENGINEERED REGULATORY T CELL | 2021-05-20 |
20210145885 | MATERIALS AND METHODS FOR TREATING VITILIGO | 2021-05-20 |
20210145886 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2021-05-20 |
20210145887 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2021-05-20 |
20210145888 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2021-05-20 |
20210145889 | METHODS, COMPOSITIONS, AND IMPLANTABLE ELEMENTS COMPRISING STEM CELLS | 2021-05-20 |
20210145890 | DYSTROPHIN GLYCOPROTEIN COMPLEX SEQUESTERS YAP TO INHIBIT CARDIOMYOCYTE PROLIFERATION | 2021-05-20 |
20210145891 | METHODS OF IMPROVING CELL-BASED THERAPY | 2021-05-20 |
20210145892 | Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof | 2021-05-20 |
20210145893 | Compositions to amplify cardiac stem cells in vitro and in viv | 2021-05-20 |
20210145894 | CELL-BASED THERAPY FOR THE PULMONARY SYSTEM | 2021-05-20 |
20210145895 | IMMUNOISOLATION DEVICE | 2021-05-20 |
20210145896 | Methods of Treating Cancer Using Bacteria Expressing c-di-AMP | 2021-05-20 |
20210145897 | AGENT FOR PREVENTING OR TREATING FAT-ASSOCIATED DISEASES AND/OR INFLAMMATION | 2021-05-20 |
20210145898 | MUSCLE-MODIFYING AGENT | 2021-05-20 |
20210145899 | ANTIFUNGAL AND ANTIMICROBIAL USES OF BACILLUS SUBTILIS CONTAINING COMPOSITIONS | 2021-05-20 |
20210145900 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2021-05-20 |
20210145901 | FREEZE-DRIED FORMULATIONS INCLUDING NANOPARTICLES AND METHODS OF FREEZE-DRYING | 2021-05-20 |
20210145902 | NOVEL LACTIC ACID BACTERIA AND USE THEREOF | 2021-05-20 |
20210145903 | Lactobacillus Plantarum LP33 and Use Thereof in Preparation of Product for Promoting Lead Excretion | 2021-05-20 |
20210145904 | Use of Lactobacillus Plantarum S58 in Preparation of Product for Alleviating Spicy Food-Induced Damage to Digestive System | 2021-05-20 |
20210145905 | LACTOBACILLUS FORMULATIONS WITH IMPROVED STABILITY AND EFFICACY | 2021-05-20 |
20210145906 | COMPOSITIONS AND METHODS FOR TREATING DISEASES | 2021-05-20 |
20210145907 | ZIKA VIRUS STRAINS FOR TREATMENT OF GLIOBLASTOMA | 2021-05-20 |
20210145908 | COMPOSITIONS COMPRISING FUCOXANTHIN AND USE THEREOF IN PREVENTION AND TREATMENT OF FATTY LIVER DISEASE | 2021-05-20 |